Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
36.5M
-
Shares change
-
+3.87M
-
Total reported value, excl. options
-
$3.71B
-
Value change
-
+$392M
-
Put/Call ratio
-
0.76
-
Number of buys
-
132
-
Number of sells
-
-112
-
Price
-
$101.65
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2017
289 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2017.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.5M shares
of 152M outstanding shares and own 23.98% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.5M shares), VANGUARD GROUP INC (3.01M shares), Select Equity Group, L.P. (2.43M shares), BROWN CAPITAL MANAGEMENT LLC (2.15M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.95M shares), Neuberger Berman Group LLC (1.9M shares), BAMCO INC /NY/ (1.51M shares), Mairs & Power INC (1.39M shares), Jackson Square Partners, LLC (1.09M shares), and STATE STREET CORP (990K shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.